Vergelijking

Glepaglutide vs. Semax

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

geen gegevens

80714-61-0

Molecuulmassa

geen gegevens

813.92 g/mol

Halfwaardetijd

geen gegevens

0.3 h

Sequentie

geen gegevens

Met-Glu-His-Phe-Pro-Gly-Pro

Werkingsmechanisme

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Semax

Semax is a tetracosactide fragment analog without hormonal activity at MC2R. Proposed mechanisms include elevation of BDNF and NGF in hippocampus and striatum (in animal models), modulation of dopamine metabolism, and neuroprotective effects via anti-apoptotic pathways. A clear primary receptor is not established.

Bewijsbasis

Hoogste bewijs

Humane RCT

Humane studie

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Glepaglutide	Semax
Duitsland	Niet goedgekeurd	Niet goedgekeurd
RU	—	Op recept
Verenigde Staten	Niet goedgekeurd	Niet goedgekeurd

Volledige vermeldingen

Glepaglutide

Volledige vermelding →

Semax

Volledige vermelding →

Frequently asked questions

What is the difference between Glepaglutide and Semax?: Glepaglutide is classified as "Onderzoek (overig)", while Semax is classified as "Onderzoek (overig)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Semax: Synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Approved in Russia for ischaemic stroke, cognitive function and ADHD in children. Western phase-3 trials absent. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Glepaglutide or Semax?: The highest available evidence level is "Humane RCT" for Glepaglutide and "Humane studie" for Semax. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Glepaglutide and Semax in Germany and the United States?: Duitsland: Glepaglutide — Niet goedgekeurd, Semax — Niet goedgekeurd. Verenigde Staten: Glepaglutide — Niet goedgekeurd, Semax — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.

Country

Glepaglutide

Semax

Duitsland

Niet goedgekeurd

—

Op recept

Verenigde Staten

Niet goedgekeurd

Frequently asked questions

What is the difference between Glepaglutide and Semax?

Glepaglutide is classified as "Onderzoek (overig)", while Semax is classified as "Onderzoek (overig)". Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. Semax: Synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). Approved in Russia for ischaemic stroke, cognitive function and ADHD in children. Western phase-3 trials absent. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Glepaglutide or Semax?

The highest available evidence level is "Humane RCT" for Glepaglutide and "Humane studie" for Semax. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Glepaglutide and Semax in Germany and the United States?

Duitsland: Glepaglutide — Niet goedgekeurd, Semax — Niet goedgekeurd. Verenigde Staten: Glepaglutide — Niet goedgekeurd, Semax — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.